Clarita Saldarriaga Vargas

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 8

Top Topics

Neuroendocrine Tumors

Intellectual Disability

Top Venues

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Radiation and environmental biophysics

This page only lists publications with an associated author ORCID identifier.

Publications

Clarita Saldarriaga Vargas, Lara Struelens, Matthias D'Huyvetter, Vicky Caveliers, Peter Covens
Assessment of mouse-specific pharmacokinetics in kidneys based on 131 I activity measurements using micro-SPECT. EJNMMI physics 9 (1) (2022)
Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers, Amelie Coolkens, Sunay Rodriguez Pérez, Noami Daems, Charlotte Duchemin, Melissa Crabbé, Tomas Opsomer, Clarita Saldarriaga Vargas, Reinhard Heinke, Laura Lambert, Cyril Bernerd, Andrew R Burgoyne, Thomas Elias Cocolios, Thierry Stora, Maarten Ooms
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [ 153 Sm]Sm-DOTA-TATE. Pharmaceutics 14 (12) (2022)
Clarita Saldarriaga Vargas, Lara Struelens, Matthias D'Huyvetter, Vicky Caveliers, Peter Covens
A Realistic Multi-region Mouse Kidney Dosimetry Model to Support the Preclinical Evaluation of Potential Nephrotoxicity of Radiopharmaceutical Therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2022)
Wei Bo Li, Céline Bouvier-Capely, Clarita Saldarriaga Vargas, Michelle Andersson, Balázs G Madas
Heterogeneity of dose distribution in normal tissues in case of radiopharmaceutical therapy with alpha-emitting radionuclides. Radiation and environmental biophysics 61 (4) (2022)
Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers, Amelie Coolkens, Sunay Rodriguez Pérez, Noami Daems, Charlotte Duchemin, Melissa Crabbé, Tomas Opsomer, Clarita Saldarriaga Vargas, Reinhard Heinke, Laura Lambert, Cyril Bernerd, Andrew R Burgoyne, Thomas Elias Cocolios, Thierry Stora, Maarten Ooms
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [ 153 Sm]Sm-DOTA-TATE. Pharmaceutics 14 (12) (2022)
Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers, Amelie Coolkens, Sunay Rodriguez Pérez, Noami Daems, Charlotte Duchemin, Melissa Crabbé, Tomas Opsomer, Clarita Saldarriaga Vargas, Reinhard Heinke, Laura Lambert, Cyril Bernerd, Andrew R Burgoyne, Thomas Elias Cocolios, Thierry Stora, Maarten Ooms
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [ 153 Sm]Sm-DOTA-TATE. Pharmaceutics 14 (12) (2022)
Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers, Amelie Coolkens, Sunay Rodriguez Pérez, Noami Daems, Charlotte Duchemin, Melissa Crabbé, Tomas Opsomer, Clarita Saldarriaga Vargas, Reinhard Heinke, Laura Lambert, Cyril Bernerd, Andrew R Burgoyne, Thomas Elias Cocolios, Thierry Stora, Maarten Ooms
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [ 153 Sm]Sm-DOTA-TATE. Pharmaceutics 14 (12) (2022)
Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers, Amelie Coolkens, Sunay Rodriguez Pérez, Noami Daems, Charlotte Duchemin, Melissa Crabbé, Tomas Opsomer, Clarita Saldarriaga Vargas, Reinhard Heinke, Laura Lambert, Cyril Bernerd, Andrew R Burgoyne, Thomas Elias Cocolios, Thierry Stora, Maarten Ooms
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [ 153 Sm]Sm-DOTA-TATE. Pharmaceutics 14 (12) (2022)